Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study examines the effect of Entresto on central hemodynamic parameters during exercise
in patients with diastolic dysfunction following acute myocardial infarction. Half of the
patients will receive Entresto and the other half will receive placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Jacob Moller
Collaborators:
Danish Heart Foundation Odense University Hospital Odense University Hospital Free Research Fund Odense University Hospital- Rigshospitalet Fund Rigshospitalet, Denmark